SEC Insider Transactions from Gupta Shalabh K..

Last updated: 2026-03-14 11:23 UTC | Total transactions: 10

Gupta Shalabh K. has filed 10 insider transactions across 1 company since March 2023.

Most recent transaction: a grant/award of 325000 shares of Unicycive Therapeutics, Inc. ($UNCY) on July 28, 2025.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
July 28, 2025 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO A Stock Options 325000 $0.00 968,951.0000 12,302,059 50.47% 2.64%
Aug. 12, 2024 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO A Stock Options 232868 $0.00 6,439,505.0000 9,405,285 3.75% 2.48%
April 15, 2024 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO A Stock Options 1319583 $0.00 6,206,637.0000 34,912,692 27.00% 3.78%
Aug. 28, 2023 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO A Stock Options 4684775 $0.00 4,988,798.0000 15,234,570 1540.93% 30.75%
July 11, 2023 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO M Common Stock 104612 $0.00 2,527,449.0000 15,234,570 4.32% 0.69%
July 11, 2023 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO M Series A-1 Convertible Preferred Stock 50 $1000.00 0.0000 15,234,570 100.00% 0.00%
July 11, 2023 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO M Warrant (right to buy 79252 $0.00 79,252.0000 15,234,570 9999.99% 0.52%
July 11, 2023 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO M Warrant (right to buy) 72047 $0.00 72,047.0000 15,234,570 9999.99% 0.47%
July 11, 2023 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO M Warrant (right to buy) 115275 $0.00 115,275.0000 15,234,570 9999.99% 0.76%
March 8, 2023 Unicycive Therapeutics, Inc. $UNCY Gupta Shalabh K. CEO A Series A Convertible Preferred Stock 50 $1000.00 50.0000 15,057,049 9999.99% 0.00%